| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 423,444 | 351,220 | 416,840 | 527,658 | | Cost of Revenue | 466,146 | 193,440 | 250,676 | 433,302 | | | Gross Profit | (42,702) | 157,780 | 166,164 | 94,356 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (133,916) | 76,960 | 81,581 | 8,101 | | Non Recurring | 996 | 100,653 |
-
|
-
| | Others | 14,253 | 14,675 | 14,480 | 13,884 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 75,965 | (34,508) | 70,103 | 72,371 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,210) | 3,298 | 2,193 | 2,658 | | Earnings Before Interest And Taxes | 80,136 | (31,210) | 72,296 | 73,497 | | Interest Expense | 20,543 | 16,061 | 17,176 | 19,379 | | Income Before Tax | 59,593 | (47,271) | 55,120 | 54,118 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (4,164) |
-
|
-
| (1,532) | | | | Net Income From Continuing Ops | 59,593 | (47,271) | 55,120 | 54,118 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 55,429 | (47,271) | 55,120 | 54,118 | | Preferred Stock And Other Adjustments | 2,460 | (1,100) | (1,360) | (34,054) | | | Net Income Applicable To Common Shares | $57,889 | ($48,371) | $53,760 | $20,064 |
|
0.20% Nasdaq 
1.25 (2.31%) 
Income Statement
